We are live on
!
Find out more
Catalyst Pharmaceutical
CPRX
CPRX
380 hedge funds and large institutions have $2.59B invested in Catalyst Pharmaceutical in 2026 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 146 increasing their positions, 120 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
43% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 40
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
22% more repeat investments, than reductions
Existing positions increased: 146 | Existing positions reduced: 120
7% more capital invested
Capital invested by funds: $2.42B → $2.59B (+$164M)
2% more funds holding
Funds holding: 373 → 380 (+7)
1.07% more ownership
Funds ownership: 84.57% → 85.63% (+1.1%)
31% less call options, than puts
Call options by funds: $3.38M | Put options by funds: $4.88M
Holders
380
Holders Change
+7
Holders Change %
+1.88%
% of All Funds
4.68%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
57
Increased
146
Reduced
120
Closed
40
Calls
$3.38M
Puts
$4.88M
Net Calls
-$1.5M
Net Calls Change
-$1.33M
Top Buyers
Top Sellers
| 1 |
Fundsmith LLP
London,
United Kingdom
|
-$60M |
| 2 |
DM
Deerfield Management
New York
|
-$23.1M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$15.8M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$12.9M |
| 5 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
-$12.6M |
